Allergy/Imm

Your Article Summary

See Latest Articles

Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
Current Opinion in Immunology, 06/22/09

Kayed R et al. - Considerable effort over the last decade has been directed toward the development of vaccines for AD; these have been primarily directed against the A beta peptide, a component of senile plaques. More recently, alternative approaches have begun to target the microtubule binding protein tau, a component of neurofibrillary tangles. Immunotherapies based upon oligomeric species of tau represent a promising new approach for AD.

Today in Neurologic/Ophthalmic...keeping you current

Receive free subspecialty "5-minute updates" via email

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: Design and lessons from a 16-year observational study
Clinical Therapeutics, 10/16/09

The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 11/03/09

Interferon-gamma–Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo
Clinical Cancer Research, 10/19/09

See All of Neurologic/Ophthalmic

Today in Vaccine/Immunotherapy...keeping you current

Receive free subspecialty "5-minute updates" via email

Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09

Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies
International Journal of Epidemiology, 10/14/09

Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the age of remission?
Expert Opinion on Investigational Drugs, 10/13/09

See All of Vaccine/Immunotherapy